How Metabolomics Can Raise the Bar in Drug Development
An Interview with Metabolon Chief Scientific Officer Ranga Sarangarajan, Ph.D. So why has this recognized R&D leader now chosen to focus on metabolomics? We sat down with Ranga to get his take on this rapidly growing technology and the potential it holds to propel drug development.